Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

CONCLUSIONS: Among statin-intolerant patients, treatment with bempedoic acid was associated with a lower risk of major adverse cardiovascular events (death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or coronary revascularization). (Funded by Esperion Therapeutics; CLEAR Outcomes ClinicalTrials.gov number, NCT02993406.).PMID:36876740 | DOI:10.1056/NEJMoa2215024

Source: Atherosclerosis - March 6, 2023 Category: Cardiology Authors: Steven E Nissen A Michael Lincoff Danielle Brennan Kausik K Ray Denise Mason John J P Kastelein Paul D Thompson Peter Libby Leslie Cho Jorge Plutzky Harold E Bays Patrick M Moriarty Venu Menon Diederick E Grobbee Michael J Louie Chien-Feng Chen Na Li LeAn Source Type: research